WASHINGTON, D.C. — After weeks of testimony, the federal hearing that could reshape the future of the U.S. cannabis industry has officially ended. Now marijuana businesses across Michigan and Ohio are waiting to learn whether the biggest federal cannabis policy change in more than 50 years will finally become reality—or whether the process will drag
WASHINGTON DC — The federal government spent the opening day of historic marijuana rescheduling hearings Monday making arguments that would have been almost unimaginable just a few years ago: cannabis has accepted medical use, carries lower abuse potential than drugs in Schedule I and II, and presents a lower overdose risk than opioids and alcohol.
Cannabis Industry Says It Has No Voice In Upcoming DEA Hearing That Could Affect Taxes, Research And Future Growth LANSING – Michigan's medical marijuana market has nearly vanished, generating just $322,350 in sales during May, according to the Michigan Cannabis Regulatory Agency. Yet a federal debate centered on marijuana's medical value could have sweeping consequences
NORML says agency misapplied federal law by excluding all supporters of cannabis reform from June 29 proceedings WASHINGTON, DC - The National Organization for the Reform of Marijuana Laws (NORML) is accusing the Drug Enforcement Administration of creating a one-sided hearing process that could influence the future of federal marijuana policy and the financial outlook
